Standout Papers

Kidney Disease as a Risk Factor for Development of Cardiovascular Disease 2003 2026 2010 2018 2.9k
  1. Kidney Disease as a Risk Factor for Development of Cardiovascular Disease (2003)
    Mark J. Sarnak, Andrew S. Levey et al. Circulation
  2. A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease (2009)
    Marc A. Pfeffer, Emmanuel A. Burdmann et al. New England Journal of Medicine
  3. Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure (2013)
    Karl Swedberg, James B. Young et al. New England Journal of Medicine

Immediate Impact

5 from Science/Nature 70 standout
Sub-graph 1 of 11

Citing Papers

Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association
2023 Standout
Critical Reanalysis of the Mechanisms Underlying the Cardiorenal Benefits of SGLT2 Inhibitors and Reaffirmation of the Nutrient Deprivation Signaling/Autophagy Hypothesis
2022 Standout
87 intermediate papers

Works of Marc A. Pfeffer being referenced

Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure
2013 Standout
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
2009 Standout
and 10 more

Author Peers

Author Last Decade Papers Cites
Marc A. Pfeffer 2188 2862 2222 39 6.3k
Patrick S. Parfrey 1727 3181 1776 64 5.4k
Patrick S. Parfrey 1313 4600 2323 44 7.6k
Donal Reddan 2245 2780 1235 68 5.2k
Annamaria T. Kausz 805 3823 1464 42 7.7k
Shelly Sapp 2251 1353 3333 57 7.0k
John D. Harnett 1050 3999 2916 47 6.1k
David A. Goodkin 1841 6003 769 56 8.7k
Gloria M. Kent 1040 4116 2759 26 5.8k
Piero Ruggenenti 600 2285 1483 61 4.9k
Yoshiharu Tsubakihara 1258 3061 573 141 4.8k

All Works

Loading papers...

Rankless by CCL
2026